Dr. Dasilva discusses the evolving management of generalized pustular psoriasis (GPP), highlighting the impact of targeted interleukin (IL)-36 receptor inhibition for this potentially life-threatening disease.
Dr. Gooderham discusses using systemic Janus kinase (JAK) inhibitors like upadacitinib in patients with atopic dermatitis. She reviews appropriate indications for patient selection with JAK
Iltefat Hamzavi, MD, discusses the evolving role of Janus kinase (JAK) inhibition in the treatment of vitiligo. He compares JAK inhibitors such as topical ruxolitinib
Alexa Hetzel, PA-C, discusses the clinical efficacy of a non-steroidal topical JAK inhibitor that helps patients with vitiligo achieve significant facial repigmentation over 52 weeks.
Tina Bhutani, MD, MAS, FAAD, discusses new data presented at the 2026 American Academy of Dermatology annual meeting for the treatment of generalized pustular psoriasis
Walter J. Liszewski, MD, an associate professor of dermatology at Northwestern University, discusses mechanisms of action to consider for treatment of patients with prurigo nodularis.
Raj Chovatiya, MD, PhD, MSCI, an associate professor at Rosalind Franklin University of Medicine and Science Chicago Medical School and founder and director of the
Harrison Nguyen, MD, MBA, MPH, FAAD, the managing director of Harrison Dermatology and Research Group and clinical assistant professor of dermatology at the University of
David Seiter, FNP-C, shares a patient success story involving a teenage patient with severe atopic dermatitis that achieved complete skin clearance within one week after
Leonardo Tjahjono, MD, FAAD, a clinical dermatologist at George Washington University in Washington, DC, discusses dosing regimens for spesolimab (Spevigo) every 4 weeks vs 12
Boni Elewski, MD, a professor and chair of dermatology at the University of Alabama in Birmingham, Alabama, discusses the characteristics and diagnosis of generalized pustular
Angela Lamb, MD, an associate professor of dermatology at the Icahn School of Medicine at Mount Sinai in New York, discusses recent advancements in understanding
Tristan Hasbargen, PA-C, of Dermatology Associates of Tallahassee, discusses the treatment of Vitiligo, with a focus on helping patients develop realistic expectations for the repigmentation
David Rosmarin, MD, the chair of the Department of Dermatology at Indiana University in Indianapolis, discusses results from a pooled subgroup analysis of the 104-week
Ted Lain, MD, MBA, a board-certified dermatologist at Sanova Dermatology in Austin, Texas, discusses the randomized phase 3 THRIVE-AA1 trial (NCT04518995), which assessed the safety
Christopher Bunick, MD, PhD, an associate professor of dermatology at Yale School of Medicine in New Haven, Connecticut, discusses a poster presentation comparing the itch
Leon Kircik, MD, a board-certified dermatologist at the Icahn School of Medicine at Mount Sinai in New York, New York, discusses the history of isotretinoin
Dr. Cotter, a board-certified dermatologist at Las Vegas Dermatology, presents a real-world case of Prurigo Nodularis, highlighting both the severity of disease presentation and the
Dr. Hilary Baldwin, the director of the Acne Treatment and Research Center in Brooklyn, New York, discusses a low-dose formulation of isotretinoin designed for better
Dr. Farberg explores the evolving treatment landscape for alopecia areata, with a focus on JAK inhibitors and their role in selectively targeting immune pathways involved
Dr. Shahriari reviews the FDA’s decision to remove certain “black box” warnings for hormone replacement therapy (HRT) and discusses how this shift may influence treatment
Alexa Hetzel, PA-C, outlines the journey of getting a case study published. The process begins with picking an interesting patient case, thoroughly documenting the treatment
Dr. Blauvelt highlights the clinical significance of aiming for 100% skin clearance in patients with psoriasis based on a presentation at DEF Essential Resource Meeting
Kara Gooding, PA-C, shares valuable insights on decoding benign versus malignant pink bumps based on a presentation at DEF Essential Resource Meeting 2026 (DERM2026) NP/PA
Andrea Nguyen, PA-C, MS, provides a detailed recap of her presentation on HS, which addressed the critical need for a multifactorial management approach, highlighting the
Dr. Cotter presents several emerging technological innovations in dermatology aimed at enhancing the management of moles and melanoma. First, he discusses an AI-augmented handheld tool
Andrew Mastro, MS, PA-C, recounted his experience on a panel called “What’s Behind the Curtain?” where experts answered top audience questions using case-based pearls based
Dr. Dasilva examines longstanding laboratory monitoring practices in dermatology and encourages clinicians to reconsider routine testing as new evidence emerges. He reviews monitoring recommendations for
Dr. Bhutani discusses the unique presentation of inflammatory skin diseases in patients with skin of color, highlighting important diagnostic and treatment considerations for Psoriasis, Atopic
Dr. McMichael shares practical leadership insights for building and sustaining a successful dermatology department. She emphasizes creating a strong departmental culture in which every team
Dr. Elbuluk reviews practical strategies for evaluating and treating hyperpigmentation, hypopigmentation, and depigmentation in patients with skin of color. She emphasizes that accurate diagnosis and
Dr. Mirmirani discusses hair loss during menopause, an often overlooked concern that can significantly affect women during the transition through midlife. She presents a 3-pillar
Dr. Lio explores how dermatologists can extend their influence beyond traditional one-on-one patient care through entrepreneurial, advisory, and professional opportunities across the healthcare industry. He
Dr. Joanna Rosen discusses the emotional impact that alopecia areata can have on families, drawing on her experiences as both a clinical psychologist specializing in
Dr. Victoria Mattingly discusses how individuals living with alopecia areata can navigate the workplace through authenticity, confidence, and intentional allyship. She emphasizes that each person
Dr. Victoria Barbosa recaps her presentation on alopecia areata in patients with skin of color, covering prevalance, diagnostic challenges, and treatment considerations. She notes that
Dr. Joseph Fakhoury moderated a patient panel exploring the real-world experience of living with alopecia areata and treatment with Janus kinase (JAK) inhibitors. Panelists discussed
Dr. Joseph Fakhoury discusses what patients can expect during treatment for alopecia areata, offering guidance on response timelines. He explains that responses to Janus kinase
Dr. Joseph Fakhoury provides an overview of the current treatment landscape for alopecia areata, reviewing approved Janus kinase (JAK) inhibitors for adolescents and adults, along
Dr. Abrar Qureshi emphasizes the importance of early diagnosis in hidradenitis suppurativa to improve pain management and drainage outcomes. Topics Covered: Early diagnosis of hidradenitis
Kara Mudd discusses treating difficult cases in contact dermatitis and the extra steps needed to help patients avoid allergens.
Melissa Davis discusses a challenging case of a patient with neuritic leprosy.
Dr. Husni discusses managing care for patients with psoriatic diseases.
Stephanie DePouw-Simmerman discusses her session that reviewed updates in treatment for patients with psoriasis.
Dr. Qureshi discusses his session about providing effective treatment for lupus and dermatomiasitis.
Dr. Lio discusses the complex relationship between diet and atopic dermatitis, addressing common patient questions, misconceptions, and concerns regarding dietary modifications. His presentation emphasizes the
Dr. Graber reviews emerging evidence supporting the use of energy-based devices for the treatment of Acne Vulgaris and Rosacea, highlighting how advances in laser and
Dr. Daveluy discusses practical techniques and clinical considerations for using cryoinsufflation in the treatment of Hidradenitis Suppurativa (HS). His presentation provides guidance on incorporating this
Dr. Bunick examines the ongoing discussion surrounding benzene contamination concerns in benzoyl peroxide (BPO) products, addressing questions about product safety, regulatory oversight, and best practices
Dr. Swanson highlights key developments presented at the AAD 2025 Annual Meeting, providing an overview of emerging therapies, clinical research, and treatment advances across several
Dr. Lio discusses strategies for addressing chronic itch (pruritus) in patients undergoing treatment for non-dermatologic cancers, a symptom that can significantly affect comfort, sleep quality,
Dr. Daveluy explores the important relationship between nutrition and dermatologic therapies, discussing how dietary choices can influence the effectiveness, absorption, and side effect profiles of
Dr. Jennifer Hsiao shares emerging strategies for treating recalcitrant hidradenitis suppurativa when standard therapies fail. Topics Covered: Management of treatment-resistant HS Emerging therapies and clinical
Dr. Bunick provides a comprehensive review of the evolving role of antibiotics in treating Acne Vulgaris and Rosacea, examining current evidence on their benefits, limitations,
Dr. Chovatiya highlights key insights from a symposium presented at the AAD 2025 Annual Meeting, focusing on the diagnosis and management of **Chronic Hand Eczema
Drawing from his presentation at the AAD 2025 Annual Meeting, Dr. Rosmarin reviews practical strategies for maximizing treatment outcomes with Ruxolitinib> cream in patients with
Dr. Hamzavi reviews the role of surgical intervention in the management of Vitiligo, focusing on identifying appropriate candidates and outlining the available procedural techniques for
Dr. Hamzavi reviews key takeaways from his presentation during the AAD 2025 Annual Meeting session on surgical management of **Hidradenitis Suppurativa (HS). His discussion focuses
Drawing from his presentation at the AAD 2025 Annual Meeting, Dr. Drucker reviews findings from a network meta-analysis comparing systemic therapies for Atopic Dermatitis. His
In this recap of his presentation at the AAD 2025 Annual Meeting, Dr. Chovatiya examines the social and structural disparities that influence the diagnosis, treatment,
Dr. Gooderham reviews the evolving role of JAK inhibitors in the treatment of Psoriasis, focusing on how different mechanisms of JAK inhibition may influence therapeutic
Drawing from his presentation at the AAD 2025 Annual Meeting, Dr. Seneschal reviews the immune mechanisms underlying Vitiligo and explains why long-term maintenance therapy is
In the sixth installment of this series on skin glycation and aging, Dr. Draelos reviews patient-reported outcomes from a recently published clinical study evaluating the
Dr. Valacchi reviews histological findings from a study published in the March 2025 issue of Journal of Clinical and Aesthetic Dermatology that investigated the effects
Dr. Draelos reviews the methodology and findings of a clinical study published in the March 2025 issue of the Journal of Clinical and Aesthetic Dermatology,
In the third installment of The Science of Skin Glycation series, Drs. Draelos and Valacchi discuss emerging research on the potential role of rosemary extract
Drs. Watchmaker and Bucay explore how rosemary extract may help counter glycative stress and improve visible signs of skin aging from the inside out. Topics
In this first installment of a six-part series, Drs. Watchmaker and Bucay explore how glycative stress impacts skin health and aging. Their discussion focuses on
